Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics

NCT06591468 is registered in ClinicalTrials.gov with Han Ying as lead sponsor.

NCT NCT06591468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06591468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
Lead sponsor
Han Ying
Phase
Phase 2/3
Overall status
Enrolling by invitation
Start date
October 30, 2024
Completion date
December 31, 2027
Enrollment
244 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis (pbc)